본문 바로가기
bar_progress

Text Size

Close

Cell Biotech Accelerates Expansion into Asian Market...Participates in 'Vitafoods Asia 2025'

Discussions on New Markets Including Thailand, the Philippines, and Vietnam

Cell Biotech announced on September 18 that it participated in 'Vitafoods Asia 2025,' held in Bangkok, Thailand from September 17 to 19 (local time). Cell Biotech joined the exhibition with an independent booth to promote 'DuoLac, probiotics 221 times stronger,' and aims to seek business opportunities to expand exports in the Asian market.


Cell Biotech Accelerates Expansion into Asian Market...Participates in 'Vitafoods Asia 2025' Booth view of Cell Biotech at 'Vitafoods Asia 2025'. Cell Biotech


Vitafoods Asia 2025 is the largest health functional food exhibition in Asia, held over three days at the Queen Sirikit National Convention Center (QSNCC) in Bangkok. This year, more than 650 global companies and over 13,000 attendees are expected to participate.


DuoLac is a leading probiotic brand from South Korea. It has consistently participated in major global health functional food exhibitions, including Vitafoods Europe, China HNC, and the United States SSW. This year, it is drawing attention by showcasing a maximum of 221 times stronger intestinal survival rate, thanks to its proprietary dual-coating technology. Through advanced technology, DuoLac has increased the survival rate of probiotics up to 91.6%, and human clinical trials have proven that its intestinal survival rate is up to 221 times higher compared to non-coated products.


At the Cell Biotech booth, buyers from around the world are actively engaging in consultations regarding products and exports, and discussions are ongoing to expand into new Asian markets such as Thailand, the Philippines, and Vietnam. In the 'New Product Zone,' which features innovative products, two new DuoLac products are on display. Among them, 'DuoLac Brain Guard' is a product that has demonstrated improvement in mild cognitive impairment through clinical trials of CBT probiotics. 'DuoLac Woman Probiotics,' designed for women's health, is also reportedly attracting interest from Asian buyers.


A Cell Biotech representative stated, "DuoLac has proven 221 times stronger intestinal survival through its proprietary dual-coating technology, is exported to 55 countries worldwide including Singapore and Indonesia, and has maintained the top global export ranking for 12 consecutive years. Through this year's Vitafoods Asia, we aim to further strengthen our presence in the Asian market and will continue to invest in research and development to enhance the competitiveness of K-Probiotics."


© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Special Coverage


Join us on social!

Top